ORIC Pharmaceuticals (NASDAQ: ORIC)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of ORIC Pharmaceuticals (NASDAQ: ORIC) through any online brokerage.
The latest price target for ORIC Pharmaceuticals (NASDAQ: ORIC) was reported by Citigroup on Friday, May 20, 2022. The analyst firm set a price target for 9.00 expecting ORIC to rise to within 12 months (a possible 101.34% upside). 7 analyst firms have reported ratings in the last year.
The stock price for ORIC Pharmaceuticals (NASDAQ: ORIC) is $4.47 last updated July 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for ORIC Pharmaceuticals.
ORIC Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for ORIC Pharmaceuticals.
ORIC Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.